Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 22.72 | 41.38 |
PEG Ratio (TTM) | 0.22 | 2.02 |
P/S Ratio (TTM) | -142.06 | 46.69 |
P/B Ratio (TTM) | 1.08 | 0.97 |
P/FCF Ratio (TTM) | -299.66 | 13.99 |
Price to 5YR AVG Earnings Ratio | N/A | 27.87 |
Price to 5YR AVG FCF Ratio | N/A | 26.98 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.31% | 2.93% |
ROE (TTM) | 9.50% | 7.46% |
Net Profit Margin (TTM) | -628.00% | 18.31% |
ROIC 5YR AVG | N/A | 8.21% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 74.01% | 240.42% | N/A |
Revenue | 215.52% | 277.69% | N/A |
Net Income | 71.28% | 252.46% | N/A |
Cash Flow | -41.27% | 47.93% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | N/A | 2.32 |
Quick Ratio (TTM) | N/A | 2.27 |
D/E Ratio (TTM) | 0.09 | 0.73 |
Interest Coverage (TTM) | 13.84 | 13.29 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 6.52 | 8.05 |
LTL to 5YR AVG FCF | N/A | 8.96 |
Shares Outstanding Growth 5YR AVG | N/A | -2.68% |